NO921159D0 - Tiazolidinon- og oksazolidinonderivater, fremgangsmaate til fremstilling derav, samt anvendelse av derivatene som vasodilatorer - Google Patents
Tiazolidinon- og oksazolidinonderivater, fremgangsmaate til fremstilling derav, samt anvendelse av derivatene som vasodilatorerInfo
- Publication number
- NO921159D0 NO921159D0 NO921159A NO921159A NO921159D0 NO 921159 D0 NO921159 D0 NO 921159D0 NO 921159 A NO921159 A NO 921159A NO 921159 A NO921159 A NO 921159A NO 921159 D0 NO921159 D0 NO 921159D0
- Authority
- NO
- Norway
- Prior art keywords
- derivatives
- tiazolidinon
- oxsazolidinon
- vasodilators
- procedures
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/14—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyrrole Compounds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Silver Salt Photography Or Processing Solution Therefor (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6308891 | 1991-03-27 | ||
JP10275191 | 1991-05-08 | ||
JP33030491 | 1991-12-13 |
Publications (3)
Publication Number | Publication Date |
---|---|
NO921159D0 true NO921159D0 (no) | 1992-03-25 |
NO921159L NO921159L (no) | 1992-09-28 |
NO304311B1 NO304311B1 (no) | 1998-11-30 |
Family
ID=27298042
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO921159A NO304311B1 (no) | 1991-03-27 | 1992-03-25 | Tiazolidinon- og oksazolidinonderivater og farmas°ytisk preparat |
Country Status (23)
Country | Link |
---|---|
US (2) | US5298516A (no) |
EP (1) | EP0506434B1 (no) |
JP (1) | JPH0780859B2 (no) |
KR (1) | KR0152097B1 (no) |
CN (2) | CN1031824C (no) |
AT (1) | ATE118770T1 (no) |
AU (1) | AU647599B2 (no) |
CA (1) | CA2064108C (no) |
CZ (1) | CZ282529B6 (no) |
DE (1) | DE69201451T2 (no) |
DK (1) | DK0506434T3 (no) |
ES (1) | ES2072095T3 (no) |
FI (1) | FI106260B (no) |
HK (1) | HK123595A (no) |
HU (2) | HU217969B (no) |
IE (1) | IE67383B1 (no) |
IL (1) | IL101395A (no) |
IS (1) | IS1746B (no) |
NO (1) | NO304311B1 (no) |
NZ (1) | NZ242154A (no) |
PH (1) | PH30493A (no) |
RU (1) | RU2055073C1 (no) |
TW (1) | TW226015B (no) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3454531B2 (ja) * | 1991-11-07 | 2003-10-06 | 三共株式会社 | ニトロキシアルキルアミド誘導体 |
CA2158368A1 (en) * | 1993-03-15 | 1994-09-29 | Jan Bron | Use of substituted alkyl nitrates for the treatment of pathologically raised intraocular pressure |
DE4429461A1 (de) * | 1994-08-19 | 1996-02-22 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten |
MX9704435A (es) * | 1994-12-15 | 1997-10-31 | Sankyio Company Ltd | Compuestos de tiazolidinona y agente terapeutico o agente de prevencion para angina de pecho, que comprende los compuestos como un ingrediente activo. |
HU223094B1 (hu) * | 1995-03-02 | 2004-03-29 | Sankyo Co., Ltd. | Optikailag aktív tiazolidinonszármazékok, előállításuk, a vegyületeket hatóanyagként tartalmazó gyógyászati készítmények és tia-vagy oxazolidinonszármazékok alkalmazása gyógyászati készítmények előállítására |
US5925658A (en) * | 1995-03-02 | 1999-07-20 | Sankyo Company, Limited | Optically active thiazolidinone derivative |
WO1997000239A1 (fr) * | 1995-06-14 | 1997-01-03 | Sankyo Company, Limited | Medicament contre l'angine contenant un derive nitroxy comme ingredient actif |
BE1010768A3 (nl) * | 1996-11-26 | 1999-01-05 | Dsm Nv | Een werkwijze voor de bereiding van alpha-aminozuuramiden, alpha-aminozuren en derivaten ervan. |
IL120531A (en) | 1997-03-26 | 2006-12-31 | Yissum Res Dev Co | Nitric oxide donors and pharmaceutical compositions containing them |
WO2002069967A1 (fr) * | 2001-03-01 | 2002-09-12 | Sankyo Company, Limited | Compositions a absorption percutanee |
CA2842106A1 (en) * | 2011-07-28 | 2013-01-31 | Promentis Pharmaceuticals, Inc. | Cysteine prodrugs |
US10239847B1 (en) | 2016-03-03 | 2019-03-26 | Cellactin | Method for 2-oxothiazolidine-4-carboxylic acid for cellular glutathione |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4200640A (en) * | 1976-04-02 | 1980-04-29 | Chugai Seiyaku Kabushiki Kaisha | Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use |
GB8717068D0 (en) * | 1987-07-20 | 1987-08-26 | Fujisawa Pharmaceutical Co | Nitric ester derivative |
DE10199034I2 (de) * | 1989-04-21 | 2011-07-21 | Ei Du Pont Du Nemours & Co | Fungizide oxazolidinone. |
-
1992
- 1992-03-24 US US07/856,491 patent/US5298516A/en not_active Expired - Fee Related
- 1992-03-24 AU AU13122/92A patent/AU647599B2/en not_active Ceased
- 1992-03-25 NO NO921159A patent/NO304311B1/no not_active IP Right Cessation
- 1992-03-26 CA CA002064108A patent/CA2064108C/en not_active Expired - Fee Related
- 1992-03-26 RU SU925011508A patent/RU2055073C1/ru not_active IP Right Cessation
- 1992-03-26 FI FI921340A patent/FI106260B/fi not_active IP Right Cessation
- 1992-03-26 TW TW081102328A patent/TW226015B/zh active
- 1992-03-26 IS IS3828A patent/IS1746B/is unknown
- 1992-03-26 CZ CS92916A patent/CZ282529B6/cs not_active IP Right Cessation
- 1992-03-26 JP JP4067972A patent/JPH0780859B2/ja not_active Expired - Fee Related
- 1992-03-26 IE IE920966A patent/IE67383B1/en not_active IP Right Cessation
- 1992-03-27 DK DK92302674.4T patent/DK0506434T3/da active
- 1992-03-27 KR KR1019920005089A patent/KR0152097B1/ko not_active IP Right Cessation
- 1992-03-27 IL IL10139592A patent/IL101395A/en not_active IP Right Cessation
- 1992-03-27 CN CN92103119A patent/CN1031824C/zh not_active Expired - Fee Related
- 1992-03-27 ES ES92302674T patent/ES2072095T3/es not_active Expired - Lifetime
- 1992-03-27 EP EP92302674A patent/EP0506434B1/en not_active Expired - Lifetime
- 1992-03-27 NZ NZ242154A patent/NZ242154A/xx unknown
- 1992-03-27 HU HU9201033A patent/HU217969B/hu not_active IP Right Cessation
- 1992-03-27 PH PH44131A patent/PH30493A/en unknown
- 1992-03-27 DE DE69201451T patent/DE69201451T2/de not_active Expired - Fee Related
- 1992-03-27 AT AT92302674T patent/ATE118770T1/de not_active IP Right Cessation
-
1993
- 1993-12-06 US US08/162,675 patent/US5356918A/en not_active Expired - Fee Related
-
1995
- 1995-05-26 CN CN95106819A patent/CN1096265C/zh not_active Expired - Fee Related
- 1995-06-29 HU HU95P/P00546P patent/HU211969A9/hu unknown
- 1995-07-27 HK HK123595A patent/HK123595A/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LU91210I2 (fr) | Emodepside & Praziquantel ainsi que leurs dérivés pharmaceutiqement acceptables (PROFENDER) | |
PT976748E (pt) | Derivados de pirrolidina com actividade inibidora de fosfolipase a2 | |
JPS568361A (en) | Pyroglutamic acid derivative and analogue | |
HK1011967A1 (en) | Amide derivatives having anti-hyper cholesteremic activity their preparation and their therapeutic uses | |
ES2078654T3 (es) | Analogos de atp. | |
NO921159D0 (no) | Tiazolidinon- og oksazolidinonderivater, fremgangsmaate til fremstilling derav, samt anvendelse av derivatene som vasodilatorer | |
DK0916651T3 (da) | Phenylalkylcarboxylsyrederivater | |
NO852514L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 8-alkyltio-2-piperazino-pyrimido (5,4-d) pyrimidin-derivater. | |
HUT75647A (en) | Imidazolidinone derivatives and pharmaceutical compositions containing them, which are suitable for treament of senile dementia | |
AU4271389A (en) | Phenylalkyl or phenylalkoxyethyl substituted piperazine derivatives | |
DK424888A (da) | Naphthothiazepinderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende saadanne derivater |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |